<instructions>Your goal is to analyze the following comment and estimate how highly it will be upvoted by the Hacker News community.</instructions><comment><author>andybak</author><text>Be wary of commenting on the tone of a thread. Skimming it 39 minutes later and it seems a very reasonable, varied thread. Wait for voting to do it&amp;#x27;s thing.</text><parent_chain><item><author>carbocation</author><text>I think it&amp;#x27;s disappointing that this thread has devolved into a political discussion that is hardly related to the topic. The scientific&amp;#x2F;medical achievement here seems significant.&lt;p&gt;As an MD, the difference between calling in a script for a pill and arranging for outpatient infusion therapies is vast.</text></item></parent_chain></comment><story><title>Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent</title><url>https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/</url></story>
<instructions>Your goal is to analyze the following comment and estimate how highly it will be upvoted by the Hacker News community.</instructions><comment><author>sudosysgen</author><text>Indeed. The opportunity for prophylaxis with an oral antiviral is also amazing.</text><parent_chain><item><author>carbocation</author><text>I think it&amp;#x27;s disappointing that this thread has devolved into a political discussion that is hardly related to the topic. The scientific&amp;#x2F;medical achievement here seems significant.&lt;p&gt;As an MD, the difference between calling in a script for a pill and arranging for outpatient infusion therapies is vast.</text></item></parent_chain></comment><story><title>Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent</title><url>https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/</url></story>